|Bid||2.3600 x 0|
|Ask||2.3700 x 0|
|Day's Range||2.3300 - 2.4900|
|52 Week Range||2.3300 - 11.2900|
|Beta (3Y Monthly)||4.93|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Want to buy stocks that will experience rapid growth over the next decade? Find out why stocks like HEXO Corp (TSX:HEXO)(NYSE:HEXO) are your best bets.
Tilray Inc. (NASDAQ:TLRY) and HEXO Corp. (TSX:HEXO)(NYSE:HEXO) are two key stocks to keep an eye on as the cannabis space ramps up for winter.
Shares of Organigram plunged in early trading on Tuesday after the cannabis producer issued guidance suggesting fourth-quarter net sales will be $16.3 million.
HEXO Corp. (TSX:HEXO)(NYSE:HEXO) stock has been cut in half this year. If you want to invest in hyper-growth cannabis companies, this looks like your best chance.
Cantor Fitzgerald is predicting “green days ahead” for the battered shares that have struggled to find their footing since Canada legalized recreational pot more than a year ago.
With the stock market seemingly not favouring cannabis stocks, both CannTrust and Hexo stocks are on a constant decline, and things look terrible for the two pot producers.
Hexo Corp recently announced that it is delaying its Q4 2019 earnings report amid a $70 million financing. Is financing a little too late to the party?
Why Hexo Corp. (TSX:HEXO)(NYSE:HEXO) continues to be my top cannabis pick in a sector which has been completely decimated of late.
HEXO Corp. (TSX:HEXO)(NYSE:HEXO) is one of the cheapest pot stocks after its massive plunge. Could it be slated to soar as soon as 2020?
If you're new to cannabis investing, don't take unnecessary risks. Stocks like Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) and HEXO Corp. (TSX:HEXO)(NYSE:HEXO) are all you need.
Shares of Hexo Corp. slipped after the cannabis company posted a larger-than-expected fourth-quarter adjusted loss and an inventory writedown.The Gatineau, Que.-based pot producer's stock slipped as much as 10 per cent to $2.72 on the Toronto Stock Exchange, but regained some ground to close down roughly three per cent at $2.94."Our company's still young, despite all that we've accomplished, we've had some shortfalls.... We hold ourselves accountable to that," Hexo chief executive Sebastien St-Louis told a conference call with financial analysts Tuesday.Hexo posted a net loss of $56.7 million in the quarter ended July 31, compared with a loss of $10.5 million in the same quarter a year ago. Net revenue totalled $15.4 million, up from $1.4 million in the same quarter last year before the legalization of recreational cannabis in Canada and $13.0 million in its third quarter.It also took a $16.9-million inventory writedown and analysts said Hexo's adjusted earnings before interest taxes, depreciation and amortization fell short of expectations.Hexo did not provide an EBITDA figure in its quarterly release or financial statement, but Desjardins analyst John Chu estimated that it totalled a loss of $29.6-million, "well short" of the analyst's forecast of a $11.8 million adjusted EBITDA loss.BMO analyst Amy Chen said the writedown and Hexo citing "price compression" in the market "is an unsettling development considering the sizable amount of unfinished inventory held by LPs (339k kg as of August according to Health Canada)," she said in a note to clients.The earnings came after Hexo announced it was reducing its workforce by 200 jobs to adjust for expected future revenues and ensure the long-term viability of the firm. The cuts included the elimination of some executive positions and the departures of chief manufacturing officer Arno Groll and chief marketing officer Nick Davies.Hexo also said earlier this month that its net revenue for the quarter ended July 31 would be in the range of between $14.5 million to $16.5 million, down from roughly $26 million it had forecast before, due to factors including a slow retail rollout and early pricing pressure.The cannabis company also said it was withdrawing its previously issued outlook of up to $400 million in net revenue during its 2020 financial year. In its latest outlook, Hexo said expects its first-quarter net revenue to be in a range from $14 million to $18 million.The company provided cautious guidance for positive adjusted EBITDA in calendar 2020, "based on certain assumptions made by management regarding store counts in the various provinces as well as operational improvements and cost saving initiatives the company is seeking to implement." St-Louis also pulled back its previous forecast of eight U.S. states with products containing CBD, the non-intoxicating compound found in cannabis in hemp, saying it would be a more concentrated effort.Hexo's fourth-quarter results "continued a streak of disappointing updates," said Owen Bennett, an analyst with Jefferies."EBITDA positive timing was pushed out, and with the magnitude of a U.S. launch downplayed and a derivatives roll out to be delayed, while at the same time urging caution around Q1 sales... Upside to be had if they can execute on plans but no one will give them credit for this until they actually deliver," he said in a note to clientsSt-Louis told analysts the future of the cannabis industry remains bright, but it may be slower to ramp up and it is unclear which players "will be Amazon and which will be the Pets.com and forgotten.""And I think if you look to the metrics and the way Hexo is managing its business, the way we are making hard decisions on operations, and the market share we've managed to keep, that tells a much stronger story than the quarterly revenue numbers," he said. This report by The Canadian Press was first published Oct. 29, 2019.Companies in this story: (TSX:HEXO)Armina Ligaya, The Canadian Press